<DOC>
	<DOCNO>NCT00032136</DOCNO>
	<brief_summary>RATIONALE : Estrogen stimulate growth breast cancer cell . Hormone therapy use exemestane may fight breast cancer reduce production estrogen . It yet know exemestane effective tamoxifen prevent recurrence breast cancer . PURPOSE : Randomized phase III trial compare effectiveness exemestane tamoxifen treat postmenopausal woman undergone surgery remove early-stage breast cancer .</brief_summary>
	<brief_title>Exemestane Compared With Tamoxifen Treating Postmenopausal Women With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy tolerability adjuvant exemestane versus adjuvant tamoxifen postmenopausal woman early breast cancer . - Compare relapse-free survival overall survival patient treat drug . - Compare incidence contralateral breast cancer patient treat drug . - Compare safety long-term tolerability drug patient . - Compare quality life patient treat drug . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord estrogen receptor ( ER ) /progesterone receptor ( PgR ) status ( ER positive v ER negative/PgR positive v ER positive/PgR unknown ) , prior chemotherapy ( none v taxane-based vs anthracycline-based v ) , nodal status ( negative v 1-3 node positive v 4 node positive ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral tamoxifen daily - Arm II : Patients receive oral exemestane daily . Treatment arm continue minimum 5 year absence disease progression unacceptable toxicity . Quality life assess baseline month 3 12 study . Patients follow least annually . PROJECTED ACCRUAL : Approximately 4,400 patient ( 2,200 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm early adenocarcinoma breast Completely excise surgery curative intent ( R0 ) Any N OR Any primary tumor great 3 cm OR Any primary tumor grade III great 1 cm M0 No positive supraclavicular node Hormone receptor status : Estrogen and/or progesterone receptor positive PATIENT CHARACTERISTICS : Age : Any age See Menopausal status Sex : Female Menopausal status : Postmenopausal Any age bilateral oophorectomy amenorrhea least 5 year OR Age 50 : Natural amenorrhea least 1 year OR Chemotherapyinduced amenorrhea least 2 year OR Radiationinduced amenorrhea ( least 3 month since prior radiotherapy ) OR Under age 50 : If amenorrheic less 5 year ( cause ) prior hysterectomy without bilateral surgical oophorectomy , folliclestimulating hormone must assay confirm postmenopausal status Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Platelet count great 100,000/mm3 WBC great 3,000/mm3 Hepatic : SGOT SGPT less 2.5 time upper limit normal ( ULN ) Renal : Creatinine le 1.5 time ULN Cardiovascular : No uncontrolled cardiac disease No unstable angina No congestive heart failure arrhythmia require medical therapy No myocardial infarction within past 3 month Other : No severe osteoporosis No malignancy within past 5 year except adequately treat carcinoma situ cervix basal cell skin cancer No serious concurrent disease would preclude study No psychiatric disorder would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior neoadjuvant chemotherapy No 10 week since completion prior adjuvant chemotherapy Endocrine therapy : No prior adjuvant hormonal therapy breast cancer No prior neoadjuvant hormonal therapy ( prior surgery ) duration 4 week At least 4 week since prior hormone replacement therapy Radiotherapy : Not specify Surgery : See Disease Characteristics No 10 week since completion curative surgery Other : No concurrent investigational agent participation another clinical study ( except adjuvant cytotoxic chemotherapy study ) Concurrent bisphosphonates allow</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>